Clinical trials
Phase 3 trials in Poland with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 6 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 4 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 74 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 6 |
| Maria Sklodowska-Curie National Research Institute of Oncology | 5 |
| Collegium Medicum w Bydgoszczy | 3 |
| Medical University of Warsaw | 3 |
| European Mantle Cell Lymphoma Network | 2 |
| Intec Pharma Ltd. | 2 |
| Medical University of Lodz | 2 |
| Military Institute od Medicine National Research Institute | 2 |
| Polish Colorectal Cancer Study Group | 2 |
| AB Science | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute Coronary Syndrome | 3 |
| Breast Neoplasms | 3 |
| Melanoma | 3 |
| Rectal Neoplasms | 3 |
| Angina, Unstable | 2 |
| COVID-19 | 2 |
| Cardiovascular Diseases | 2 |
| Hodgkin Disease | 2 |
| Leukemia | 2 |
| Leukemia, Myeloid, Acute | 2 |
Trials
Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.